INTRODUCTION
Growing evidence suggests the link of periodontitis to many systemic diseases. Rheumatoid arthiritis (RA) is one of them. Both periodontitis and RRA share the title of being "inflammatory disease" and resulting bone destruction. Periodontitis is defined as "an inflammatory disease of the supporting tissues of the teeth caused by specific microorganisms, resulting in progressive destruction of the periodontal ligament and alveolar bone with pocket formation, recession, or both." 1 Rheumatoid arthritis is a chronic destructive inflammatory disease, characterized by the accumulation and persistence of an inflammatory infiltrate in the synovial membrane that leads to synovitis and the destruction of the joint architecture. Periodontitis and RA share many similar pathological aspects and immunological findings. In both diseases, progression consists of the continuing presence of high levels of proinflammatory cytokines. Furthermore, low levels of tissue inhibitors of metalloproteinases, high levels of matrix metalloproteinases, and prostoglandins (PGE 2 ) secreted by macrophages, fibroblasts, and other resident and migrating inflammatory cells, characterize the active stage of both diseases. 2 It has been suggested that the bacteria, involved with periodontal disease (PD), are also active in the pathogenesis of RA. 3 Several prospective clinical trials have shown that individuals with RA are more likely to experience moderate-tosevere PD compared with their healthy counterparts. 4 Some research has shown improvement in RA symptoms following successful periodontal treatment. [5] [6] [7] This is likely due to the reduction in the oral contribution to the total inflammatory burden, following the favorable periodontal treatment outcome.
Therefore, the aim of this study was to examine the effect of nonsurgical periodontal treatment on the signs and symptoms of RA in patients with PD.
MATERIALS AND METHODS
A total of 60 subjects aged 18 to 65 years with confirmed diagnosis of active RA and chronic generalized periodontitis, visiting the Department of Medicine and Orthopaedics in People's College of Medical Sciences and Research Centre and Bhopal Fracture Hospital -Bhopal, were selected for the study. A structured questionnaire was answered by each subject to ascertain the following details -history of acute/chronic systemic diseases, periodontal treatment in last 6 months, long-term medication for chronic diseases, xerostomia, subjects with habits, such as alcohol use, smoking, tobacco chewing, and pregnant and lactating women. Subjects with any of the above risk factors were excluded from the study. Those included in the study were with a confirmed diagnosis of active RA 8 and chronic generalized periodontitis 1 after controlling for the above-mentioned risk factors. Subjects were randomly divided into two groups: Group A (control group) consisted of 30 subjects who did not receive nonsurgical periodontal therapy. Group B (test group) consisted of 30 subjects who received nonsurgical periodontal therapy (scaling, root planning, and oral hygiene instructions).
Assessment of periodontal status was done by Simplified Oral Hygiene Index (OHI-S) (Greene and Vermillion 1964), 9 gingival index (GI) (Loe and Silness 1963), 9 mean percentage of bleeding sites -(the presence or absence of gingival bleeding is determined by gentle probing of the gingival crevice with a periodontal probe. The appearance of bleeding within 10 seconds indicates a positive score which was expressed as a percentage of the total number of gingival margins examined), 9 probing pocket depth (PPD), and clinical attachment level (CAL) measured at six sites per tooth. 9 Clinical and biochemical parameters, which were used to assess the severity of RA were RA disease activity score (DAS-28), 10 which includes swollen joints (SJ), tender joints (TJ), erythrocyte sedimentation rate (ESR), visual analogue scale (VAS) for physician's global assessment, and C-reactive protein (CRP).
Clinical periodontal and RA parameters were measured and recorded at baseline and again after 3 months for both the groups after subjecting group B to nonsurgical periodontal therapy including scaling, root planning, and oral hygiene instructions. Group A patients who did not receive therapy during the study were treated after the end of the study.
The values obtained were used to make a comparative analysis between the two groups (i.e., groups A and B). The data were statistically analyzed to evaluate the effect of nonsurgical periodontal therapy on the signs and symptoms of RA.
To assess all the variables in groups A and B, arithmetic mean and standard deviation were used. To compare all the variables between groups A and B, Student's t test (unpaired) was adopted and p-value was obtained. A p-value of 0.05 was assumed significant.
OBSERVATION AND RESULTS
The present study did not have any sample loss. All the patients placed in their respective group finished the study. The average age was 51 ± 9.2 and 49 ± 10.3 respectively in groups A and B. Females constituted 87% of the subjects in group A and 83% in group B.
The baseline periodontal and RA parameters are in Tables 1 and 2 respectively. All periodontal and RA parameters showed no statistical difference in groups A and B at baseline except OHI-S and mean percentage of sites with bleeding on probing (BOP), which was found to be statistically significant with p < 0.05.
The OHI-S, GI, and percentage of BOP significantly improved with p < 0.0001 in group B patients who received nonsurgical periodontal therapy. The PPD also reduced significantly in group B patients 3 months posttreatment (p < 0.0001). There was a significant gain in CAL in group B patients, 3 months after the treatment (p < 0.0171). Based on DAS-28 test, group B patients receiving periodontal therapy show significant improvement in DAS-28. Also, when disease activity of subjects was compared on the basis of DAS-28, two patients shifted from high disease activity group to moderate disease activity group, and one patient shifted from moderate disease activity to low disease activity, which showed improvement in overall inflammatory condition (Table 3) .
General Assessment score on VAS showed statistically significant improvement in the group B patients compared with group A patients. Subjects receiving periodontal therapy (group B) showed significant improvement in number of TJ (p < 0.0008) and SJ (p < 0.0001) compared with group A (Tables 4 and 5) .
DISCUSSION
This study showed that subjects suffering from moderate/ severe PD and RA, i.e., group B, when receiving nonsurgical periodontal therapy had shown overall improvement in all periodontal and RA parameters.
When groups A and B were compared, subjects in group B who received nonsurgical periodontal therapy showed statistically significant improvement in all periodontal clinical parameters including OHI-S, GI, BOP, PPD, and CAL as compared with untreated subjects in group A at 3 months. These might be related with the reduction of periodontal inflammatory status. These findings are in accordance with the previous studies done by Al-Katma et al 5 
JCDP
Nonsurgical periodontal therapy of subjects with moderate-to-severe chronic generalized periodontitis and active RA was found to reduce the severity of RA as measured by DAS-28 in group B. There was a statistically significant decrease in the DAS-28 at 3 months in subjects of group B who received nonsurgical periodontal therapy. No such change was observed in untreated group A subjects. It was observed that severe incapacity degree decreased for group B patients. This observed improvement if RA disease activity was found to be independent of disease-modifying drug therapy or other systemic factors since both the groups were matched for common risk factors for both RA and periodontitis. Further, there was no change in the drug prescription during the entire study period for both the groups. Hence, it can be concluded that this decrease in DAS-28 severity was likely to be associated with the periodontal therapy. These findings are in association with other studies done by Ortiz et al, 6 Ribeiro et al, 11 and Al-Katma et al. 5 Subjects in group B who received nonsurgical periodontal therapy showed statistically significant decrease in the number of TJ and SJ, scores of VAS for physician's global assessment when compared with untreated subjects in group A at 3 months. These findings are similar to results achieved in other studies done by Pinho et al, 7 Ribeiro et al, 11 and Ortiz et al. 6 Higher values of ESR and CRP are associated with active inflammatory disease. Values of ESR and CRP showed significant reduction after periodontal therapy in group B patients compared with untreated group A patients. Similar results have been reported by Pinho et al, 7 D'Aiuto et al, 12 Ebersole and Cappelli, 13 and Ortiz et al. 6 Periodontal diseases are systemic inflammatory conditions. Their treatment reduces the overall systemic inflammatory load. The improvement in symptoms related to RA in group B might be due to decrease in inflammatory products in the blood after periodontal therapy.
CONCLUSION
From the above-mentioned observations of this study, it may be concluded that nonsurgical periodontal therapy may contribute to a reduction in the signs and symptoms of RA.
However, further studies with higher sample size and longer study time may throw more light on the association between RA and chronic periodontitis and the effect of nonsurgical periodontal therapy on the signs and symptoms of RA. 
